2023 Rare and Orphan Disease Conference presented by C-Path
- C-Path’s Rare and Orphan Disease Program’s current and future impact on drug development in rare diseases
- The Critical Path for Rare Neurodegenerative Diseases (CP-RND) initiative’s first year impact and highlights
- How RDCA-DAP has been enhanced in the last year, and how the platform informs rare disease drug development
- Transversal solutions to address bottlenecks in drug development
When: September 11-13, 2023
Where: Washington Marriott at Metro Center
775 12th Street Northwest
Washington, DC 20005
Building a rare and orphan disease community that works. Together.
Critical Path Institute is supported by the Food and Drug Administration (FDA) of the Department of Health and Human Services (HHS) and is 55% funded by the FDA/HHS, totaling $17,612,250, and 45% funded by non-government source(s), totaling $14,203,111. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, FDA/HHS or the U.S. Government.